Michael Sha

Michael Sha

CTO, Diacarta Inc
在 diacarta.com 的电子邮件经过验证
被引用次数：1929
Cancer Diagnostic
Seyedeh Masoumeh Ghoreishi

Seyedeh Masoumeh Ghoreishi

Ph.D of radiopharmacy, Babol University of Medical Sciences
在 mubabol.ac.ir 的电子邮件经过验证
被引用次数：1097
Cancer diagnostic Receptor binding Theranostic agents Drug delivery Cancer therapy
Ananth Bommakanti

Ananth Bommakanti

Twist Bioscience
在 twistbioscience.com 的电子邮件经过验证
被引用次数：351
Ribosome Cancer diagnostic RNA Diagnostics
Muhammad Waqas Akbar

Muhammad Waqas Akbar

Yale University, USA
在 yale.edu 的电子邮件经过验证
被引用次数：174
Cancer diagnostic prognostic and theranostic biomarkers
Diya Li

Diya Li

University of Notre Dame
被引用次数：117
CNT Cancer diagnostic Point-of-care
Nina S Bondarenko

Nina S Bondarenko

Docent, Dnipro State Medical University
在 dmu.edu.ua 的电子邮件经过验证
被引用次数：112
Pathology Cancer diagnostic Tumor microenvironment Liquid biopsy NGS TEM
Lydia Meyer Turkson

Lydia Meyer Turkson

CEO, Locus Genetics
在 locusgx.com 的电子邮件经过验证
被引用次数：5
cancer diagnostic cancer drug discovery CRISPR gene editing tools
Philip Leung

Philip Leung

Imperial College London
在 imperial.ac.uk 的电子邮件经过验证
被引用次数：1
Cancer Diagnostic Precision Medicine Therapy Monitoring Volatile Biomarkers